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Abstract
Background: Despite the range of available, evidence-based treatment options for Major Depressive Disorder
(MDD), the rather low response and remission rates suggest that treatment is not optimal, yet. Computerized
attention bias modification (ABM) trainings may have the potential to be provided as cost-effective intervention as
adjunct to usual care (UC), by speeding up recovery and bringing more patients into remission. Research suggests, that
a selective attention for negative information contributes to development and maintenance of depression and that
reducing this negative bias might be of therapeutic value. Previous ABM studies in depression, however, have been
limited by small sample sizes, lack of long-term follow-up measures or focus on sub-clinical samples. This study aims at
evaluating the long-term (cost-) effectiveness of internet-based ABM, as add-on treatment to UC in adult outpatients
with MDD, in a specialized mental health care setting.
Methods/design: This study presents a double-blind randomized controlled trial in two parallel groups with
follow-ups at 1, 6, and 12 months, combined with an economic evaluation. One hundred twenty six patients,
diagnosed with MDD, who are registered for specialized outpatient services at a mental health care organization in the
Netherlands, are randomized into either a positive training (towards positive and away from negative stimuli)
or a sham training, as control condition (continuous attentional bias assessment). Patients complete eight training
sessions (seven at home) during a period of two weeks (four weekly sessions). Primary outcome measures are change
in attentional bias (pre- to post-test), mood response to stress (at post-test) and long-term effects on depressive
symptoms (up to 1-year follow-up). Secondary outcome measures include rumination, resilience, positive and negative
affect, and transfer to other cognitive measures (i.e., attentional bias for verbal stimuli, cognitive control, positive mental
imagery), as well as quality of life and costs.
Discussion: This is the first study investigating the long-term effects of ABM in adult outpatients with MDD, alongside
an economic evaluation. Next to exploring the mechanism underlying ABM effects, this study provides first insight into
the effects of combining ABM and UC and the potential implementation of ABM in clinical practice.
Trial registration: Trialregister.nl, NTR5285. Registered 20 July 2015.
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Background
Major Depressive disorder (MDD) is one of the most
prevalent mental disorders. With at least 350 million
people suffering from this disorder worldwide, it is con-
sidered the leading cause of disability, in terms of total
years lost due to disability [1]. Cost-of-illness (COI)
studies demonstrate a substantial increase of direct (i.e.,
medical and non-medical costs) and indirect costs (i.e.,
due to productivity losses and premature death) caused
by depression, leading to a high economic burden for all
nations [2].
According to the WHO mhGAP Intervention Guide [3],
health care for depression preferably consists of a combin-
ation of basic psychosocial support with antidepressant
medication or psychotherapy, including cognitive behav-
ioral therapy (CBT), interpersonal psychotherapy (IPT) or
problem-solving treatment. Although psychopharmalogical
and psychotherapeutic interventions are both considered
effective in the treatment of MDD (e.g., [4]), less than half
of the patients show response and remission to psychother-
apy [5] and the majority of patients fail to show remission
after a first treatment with standard antidepressant medica-
tion [6, 7]. Moreover, depression is characterized by high re-
currence rates [8], with up to 85 % of the recovered patients
experiencing a new episode during 15 years follow-up (for
a prospective study, see [9]), and a substantial increase in
risk of recurrence with each successive episode [10].
These rather low response and remission rates, as well
as the highly recurrent nature of the disorder indicate, that
the underlying factors maintaining depression and predis-
posing individuals to repeatedly develop new episodes, are
not very well understood, yet. In the past years, depression
research has therefore extensively focused on the iden-
tification of potential vulnerability factors for this dis-
order [8, 11]. One such cognitive vulnerability factor is
a bias in the attentional processing of emotional informa-
tion [12, 13]. Cognitive theories of depression [14, 15] pos-
tulate that information processing in depression is guided
by negative schemata, which results in a selective at-
tention for negative, schema-congruent stimuli in the
environment. This so-called negative attentional bias
is assumed to contribute to both development and
maintenance of the disorder.
Indeed, a substantial amount of studies support that,
compared to healthy individuals, the depressed show
heightened attention for negative compared to positive
or neutral information (for a meta-analysis, see [16]), es-
pecially when assessed with the dot-probe task [17].
More specifically, the bias in depression appears to oper-
ate at a later stage of information processing, as indi-
cated by longer maintained attention on negative stimuli
(for eye-tracking studies, see [18–21]) and a difficulty to
disengage attention from negative information [22].
However, not only the processing of negative stimuli is
impaired in depression. Next to this negative attentional
bias, depressed individuals also lack a positive atten-
tional bias, characterized by longer sustained attention
to positive than to neutral or negative stimuli, which is
usually found in healthy individuals [20, 21, 23].
Both, the presence of negative as well as the lack of
positive attentional biases, have been suggested to play
an important role in mood regulation. Whereas a posi-
tive attentional bias has been associated with a more
adaptive emotion regulation under stress [24] and in-
creased resilience [25], the impaired attentional disen-
gagement from negative information has been linked to
the ineffective use of emotion-regulation strategies in re-
sponse to stress [26, 27]. The latter in turn is supposed
to lead to prolonged processing of negative information,
such as during rumination and hence, to sustained nega-
tive affect. Sanchez and colleagues [22] recently provided
support for this assumption by showing that in de-
pressed patients, specifically the delayed disengagement
from negative stimuli predicts lower recovery from nega-
tive mood in response to a stressor.
Based on above-mentioned findings, researches in this
field have started to investigate attention bias modifica-
tion (ABM) paradigms, to alter attentional bias and to
examine its causal effects on symptoms in emotional
disorders with, so far, main focus on anxious populations
[28]. Up to date only a handful of studies have been
conducted in depressed samples. Most of these studies
made use of the dot-probe task [17] with increased
stimulus presentation times (e.g., [29, 30]) to allow for a
more elaborate processing of the materials and hence
tapping into the attentional bias in depression, which is
operating at a later stage of information processing [31].
In a first study, Wells and Beevers [29] showed that a
dot-probe training designed at decreasing a negative at-
tentional bias, reduces depressive symptoms in dys-
phoric students, from baseline to two weeks follow-up,
compared to a placebo ABM training, with the group
differences being mediated by a change in attentional
bias. In a comparable study, a subclinical sample of ado-
lescents with mild to severe symptoms of depression,
completed either eight sessions of active, word based-
ABM, placebo ABM or assessment-only [32]. Compared
to placebo and no-training control group, depressive
symptoms reduced significantly in the active group and
this decrease was maintained during three months
follow-up. These effects were mediated by a decrease in
rumination, which was again mediated by a change in at-
tentional bias. Promising results were also found by
Browning and colleagues [33], who provided remitted
depressed patients 14 days of dot-probe training (two
sessions per day) towards positive and away from negative
pictures or words. The researchers report an increase in
positive attentional bias after the picture-based (but not
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after the word-based) ABM, as well as reductions in de-
pressive symptoms and cortisol wakening response up to
4 weeks post-training. No such changes were found in the
placebo ABM group.
To the best of our knowledge, so far, only two ran-
domized controlled trials (RCTs) have been conducted
in samples of currently, clinically depressed individuals.
The first study, by Baert and colleagues [34], made use
of a different training paradigm than the dot-probe. By
means of a spatial curing task, they trained dysphoric in-
dividuals’ and clinically depressed patients’ attention
away from negative towards positive words. However, no
changes in bias were found and symptom improvements
appeared only in the dysphoric group. More encouraging
findings come from a just recently conducted RCT, in-
vestigating effects of a dot-probe based ABM in cur-
rently depressed (MDD) patients [35]. Compared to four
weeks placebo ABM, the same amount of active ABM
successfully reduced a negative attentional bias and in-
creased resting-state connectivity within a neural circuit
associated with attentional control over emotional infor-
mation. Although symptom reduction did not differ
across groups, only in the active training group, change
in negative attentional bias was associated with symptom
improvement, supporting the notion that negative atten-
tional bias maintains the disorder. The decrease of
symptoms in the placebo group by contrast, seemed to
be related to improved control over spatial attention.
Despite these somewhat mixed results and limited
number of studies, above-mentioned research suggests,
that ABM might be of therapeutic value for depression
and may have the potential to increase response and re-
mission rates, achieved by usual care (UC). Considering
the growing acknowledgement of the importance of self-
help interventions as adjunct to regular health care in
depression [36] and promising findings from numerous
studies on the effectiveness of computer-therapy for this
disorder (for a meta-analysis, see [37, 38]), the idea
would be very appealing to add ABM as internet-based
intervention to existing treatment services. As ABM
consists of a rather simple and straightforward computer
task and thus needs no or minimal assistance of a clin-
ician, it may flexibly be incorporated into patients’ every-
day life, being accessible 24 h a day, on every day of the
week. Moreover, the training can be followed at home,
in a familiar environment and is not associated with any
travel time and costs. Due to these advantages, ABM
may be provided to patients not only parallel to UC, but
would also be accessible during waiting period for treat-
ment. ABM thus might offer patients and effective, ac-
ceptable and budgetary affordable intervention to start
with immediately after being referred to mental health
care and bridge the, due to insufficient treatment capaci-
tates in the health care system, often unacceptable long
time between referral and start of treatment (i.e., up to
90 days or more;[39]). Next to the potential therapeutic
effects, the addition of ABM on top of regular treatment
may have favorable economic impacts through reducing
the number of sessions of outpatient care by accelerating
speed of recovery. This in turn may reduce down-stream
costs and may further positively affect return-to-work
and productivity.
Before introducing ABM in treatment programs of
depression though, more RCTs are required which address
limitations of previous studies. First and most importantly,
research needs to investigate the effectiveness of a dot-
probe based ABM training in clinical practice. Although at
least one RCT has been conducted in a sample of individ-
uals diagnosed with clinical depression [35], the potential of
implementing dot-probe based ABM in a specialized
clinical health care (and home) setting has not been tested,
yet. Second, the long-term effectiveness of ABM still needs
to be investigated. Research suggests, that ABM effects
may only become apparent over time, when the newly
acquainted cognitive processing style is repeatedly deployed
in emotional daily-life situations [17, 29, 40]. The previously
conducted ABM studies in depressed samples, however,
contained either no follow-up [34], or follow-up measures
between 2 and 4 weeks [29, 33, 35]. Only one study in-
cluded follow-up measures at 7 months [32]. If the goal is,
to ultimately apply ABM in clinical settings, it is of import-
ance to examine symptom changes across a much longer
period of time, in order to see how stable the changes are
and whether ABM is associated with higher response and
remission rates and, ideally a reduction in relapse percent-
ages. Third, samples sizes of previous studies are rather
small, varying between 14 and 29 participants per group
[29, 30, 32–34]. Given the supposedly rather small effects of
ABM [28, 41], it has been claimed that ABM research
should strive for larger sample sizes, to increase the confi-
dence regarding effect size estimates [28, 35, 41].
Aim and hypotheses
The present study aims to address above-mentioned lim-
itations by means of an adequately powered, random-
ized, double-blind, placebo-controlled trial, alongside an
economic evaluation, investigating the long-term effect-
iveness and cost-effectiveness of a dot-probe based ABM
training, as self-help intervention for clinical depression
in a specialized health care setting. One hundred twenty
six patients who are diagnosed with MDD and are regis-
tered for specialized ambulatory treatment at the mental
health care institute Pro Persona in the Netherlands, are
randomized into either a positivity training (PT) group
(ABM towards positive and away from negative stimuli)
or a sham (i.e., placebo) training (ST) group, as control
condition (continuous attentional bias assessment). Pa-
tients complete eight training sessions (of which seven
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at home via internet) during a period of two weeks.
Changes in attentional bias are assessed from pre- to post-
assessment, whereas effects on clinical symptoms are add-
itionally assessed one, six and 12 months after training.
In line with previous research on ABM in depression,
we predict that the PT group shows a stronger decrease
in negative attentional bias and therefore a stronger de-
crease in depressive symptoms over time, than the ST
group. As already suggested by findings of Wells and
Beevers [29] and Beevers and colleagues [35], training ef-
fects on depressive symptoms are thus expected to be
mediated by an decrease in negative attentional bias. Re-
cent research by Yang and colleagues [32] however sug-
gests, that the ABM effect on depressive symptoms is
not directly mediated by change in bias. Instead, a
change in bias appears to mediate a change in rumin-
ation, which in turn directly mediates the reduction of
symptoms. Therefore, we additionally explore the effects
of ABM on rumination and it’s mediating role in the ef-
fects of ABM on depression.
Although previous research suggests that a negative at-
tentional bias is associated with the use of less effective
emotion regulation strategies [26, 42] and hence lower
mood recovery from stress [22], research has not tested
the causal effects of modifying attentional bias on stress
responses in depressed samples, yet. Whereas ABM ef-
fects on symptoms are assumed to manifest themselves
over a longer period of time (see for instance, [23, 33]),
effects on mood reactivity and recovery from stress
should be visible shortly after the training already.
Hence, the present study also includes a stressful speech
task at post-assessment, as a more sensitive measure of
the potential therapeutic effects. In line with findings of
Sanchez and colleagues [22], it is hypothesized that the
PT group shows a higher mood recovery from the stres-
sor than the ST group. Moreover, effects on general
levels of resilience over time are measured.
In addition to the effects on depressive symptomatol-
ogy, rumination and stress responses, this study further
extends previous findings by investigating transference
effects to other cognitive processes, including attentional
bias for verbal emotional information and quality of
positive mental imagery, known to be impaired in de-
pression [43]. Furthermore, a measure of cognitive con-
trol is included, as previous research suggests that
depression is also associated with a lack of inhibitory
control over negative information [27] and that ABM
can increase activity in neural networks associated with
attentional control [35]. Importantly, some previous
studies found that sham-training control conditions may
lead to comparable changes in symptoms as the active
ABM condition, possibly due to the above-mentioned
increase in cognitive control, resulting from the
contingency-based learning procedure [30, 44–46].
These effects have mainly been observed in socially anx-
ious populations, whereas most studies in depressed sam-
ples found active ABM to be more effective than sham
ABM [29, 32–34]. Nevertheless, we have to consider the
possibility that both groups may show indistinguishable,
significant clinical improvements. If this is the case, it will
be important to investigate the role of (changes in) cogni-
tive control in the therapeutic effects of the training. At
the same time, previous research also suggests that ABM
training effects may depend on levels of attentional con-
trol (i.e., higher attentional control is associated with
stronger training effects; [47]). Therefore, our measure of
cognitive control will also be used to explore whether it
predicts our training effects on bias.
Finally, recent research strongly recommends adding
questions regarding patients’ expectancies, to control for
non-specific treatment effects of an intervention [48]. It has
been argued that, although active/sham control conditions
are superior to waiting-list control groups in controlling for
placebo effects, it is only possible to ascribe treatment ef-
fects to the intervention, if it can be proven that both, treat-
ment and control group have the same expectations
regarding improvement. To our knowledge, this is the first
ABM study, which actively controls for possible placebo ef-
fects of an ABM training, by measuring participants expec-
tations and the experienced credibility of the training.
Methods
Design
The study is conducted as a two-arm, double-blinded RCT,
at four locations of the Dutch mental health care institute,
Pro Persona (Arnhem, Nijmegen, Ede and Tiel). Adult
MDD patients are randomly allocated to either a positive
ABM training (PT), or a sham ABM training (ST) as
control condition. Participants complete a total of eight
training sessions distributed over two weeks (i.e., four
weekly sessions). The very first session is completed at the
mental health care institute and all other sessions via inter-
net, at participants’ home. The training sessions are
preceded and followed by an assessment (i.e., a pre- and
post-assessment) at Pro Persona and three more follow-up
assessments via the internet, one, six, and 12 months later
(see Fig. 1 for an overview of the design). The study has re-
ceived ethical approval by the medical ethics committee
Arnhem-Nijmegen (2013/373; NL45720.091.13) and is reg-
istered with trialregister.nl, number NTR5285. Any sub-
stantial protocol amendments will be communicated to all
relevant parties (i.e., medical ethics committee, trial regis-
ter, journals).
Participants
Inclusion and exclusion criteria
In order to be eligible for participation, Dutch patients
between 18 and 65, should meet the criteria for a
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diagnosis of MDD, first or recurrent according to the
DSM- IV-TR [49]1 as assessed with the Mini Inter-
national Neuropsychiatric Interview (MINI; [50]).
Exclusion criteria are (a) any psychotic disorder
(current or previous) (b) current mania, hypomania or a
history of bipolar disorder (c) acute suicidal risk (d) a
verbal IQ < 80 (e) visual disabilities that interfere with a
computer task (f ) insufficient command of the Dutch
language, (g) no regular access to a computer with inter-
net at home, and (h) insufficient experience with the use
of computers (based on the subjective estimation of the
patient). To maximize recruitment, the use of medica-
tion is routinely recorded but does not represent an ex-
clusion criterion. Likewise, the stabilization of the
dosage of medication is not required for participation.
Recruitment
We recruit 126 outpatients with a major depressive epi-
sode (first or recurrent) who are referred to specialty
care for ambulatory treatment at Pro Persona. UC in
the study is the standard care delivered in the pro-
gram for mood disorders at Pro Persona according to
the Dutch multidisciplinary guideline for depression
[51] and can be psychotherapy (e.g., CBT or IPT),
antidepressant medication, the combination of psy-
chotherapy and antidepressants or ambulatory care
provided by a specialized psychiatric nurse. Health
care consumption is closely monitored in both train-
ing groups. The MINI is administered as part of the
standard intake procedure. Patients who are eligible
based on the MINI diagnosis, are informed about the
study and the possibility to participate by the mental
health care specialists. Those who provide written
consent for being contacted by a researcher, are pro-
vided more detailed information regarding the study
via telephone. During this phone call, remaining ex-
clusion criteria are checked and eligible patients are
invited for the baseline session.
Fig. 1 Flowchart of the recruitment and study procedure. Note. MINI = Mini International Neuropsychiatric Interview; Measures at T1, Training 1
and T2 are administered at Pro Persona. Training 2–8 and all follow-up measures (T3–T5) are administered via the internet
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Randomization and blinding
Participants are randomly allocated to one of the two
groups, right before the first training session.
Randomization is computerized and stratified for de-
pression severity (<39 = moderate; 39–48 = severe; >
48 = very severe) at baseline, as assessed by the Inven-
tory of Depressive Symptomatology self-report (IDS-
SR; [52]), as well as for age (18–35 years; 36–50
years; 51–65 years). In case participants indicate, that
they want to discontinue with the study and withdraw
consent for using their data, intervention allocation is
corrected for the excluded participants.
Based on the IDS-SR score and age, the computer gen-
erates a random 5-digit number, which is linked to one
of the two training conditions and which further identi-
fies participants and their documents. This blinding code
is managed by an independent statistician and revealed
to researchers only, after all participants have completed
the last assessment. Hence, both participants and re-
searchers are blind to the training conditions.
To assess if participants remained blinded to their
group allocation, all participants fill in an awareness
check at post-test, investigating which training condition
(PT or ST) they believe they have been enrolled to.
Instruments and materials
Intervention
Attention bias modification
The attention training in this study is based on a modi-
fied version of the dot-probe task [17] and is comparable
to the task used in the studies of Wells & Beevers [29]
and Beevers et al. [35]. For this task, a set of 50 picture
pairs was created. Thirty picture pairs (12 × 8 cm) were
selected from the Nencki Affective Picture System
(NAPS; [53]), with half of the pictures displaying positive
scenes or images (e.g., landscapes or puppies) and the
other half displaying negative (i.e., dysphoric) scenes or
images (e.g., people in sad situations). All picture pairs are
matched on content and complexity and are of compar-
able emotional intensity. Extremely arousing pictures were
excluded. Another set of 20 picture pairs (8 × 12 cm) con-
tains exclusively faces from actors (10 male, 10 female), se-
lected from the Umeå University Database of Facial
Expressions [54], each of them displaying a happy and a
sad expression. An additional set of five neutral NAPS
pairs and five neutral Umeå pairs were selected for prac-
tice trials preceding the ABM assessment and training.
During each trial of the task, a white fixation cross ap-
pears in the middle of the black computer-screen. After
1500 ms, the cross disappears and two pictures, always
one positive picture and one negative picture, appear
next to each other on the screen – approximately 16 cm
apart when measured from the center of each picture.
The location of negative and positive pictures (i.e., right
or left half of the screen) is counterbalanced across
trials. In line with the reference studies by Wells and
Beevers [29] and Beevers et al. [30], a left-right ori-
ented stimulus presentation is chosen instead of a
top-down orientation. A recent meta-analysis suggests
relatively larger effect sizes for left-right than for top-
down oriented materials in the dot-probe task [45].
Moreover, the horizontal stimulus orientation has the
advantage that on relatively small computer-screens
which might be used by participants in this study, the
stimuli can be presented in a larger size.
The two pictures are randomly presented for an
interval of 1000 or 1500 ms. Following offset of the
pairs, a small arrow (i.e., probe) appears in the loca-
tion of one of the pictures, pointing either up or
down, with equal probability. Participants need to in-
dicate the direction of the arrow as quickly as pos-
sible, by pressing a corresponding response button on
the keyboard. The arrow remains on the screen until
the participant reacts to it. The computer records the
participants’ reaction time (RT; appearance to dis-
appearance of the arrow) and response accuracy. In
case participants do not respond within 3000 ms, they
are reminded to do so by the computer.
The whole task contains two sorts of trials: Assess-
ment and training trials. In the 60 assessment trials, a
set of 30 out of the 50 picture pairs is presented twice
(i.e., 18 NAPS pairs, 12 UMEA pairs). The location of
the arrow is counterbalanced across picture valence,
such that the arrow replaces negative and positive pic-
tures equally often. During the training trials, all 50
picture-pairs are used and are presented four times each,
evenly distributed across four blocks, which are sepa-
rated by a short break. In the ST, participants receive a
continued assessment, during which the probe appears
with equal probability in the location of positive and
negative pictures. In the PT, contingencies are changed:
The arrow appears in about 90 % of the trials in the lo-
cation of the positive stimulus, such that attention is
redirected away from the negative, towards the positive
stimuli. A contingency of 90 % is used to allow for as-
sessment of an attentional bias during the training ses-
sions and to keep the intent of the study from being
obvious [29]. This contingency is established by evenly
distributing 20 additional catch trials across all blocks,
during which the arrow appears in the location of the
negative picture. In the ST, these extra trials are also
added, with the arrow appearing equally often behind
the positive and the negative picture. In total, the train-
ing part thus contains 220 trials (i.e., four blocks: 50
training trials, five catch trials) and lasts about 20 min.
To increase participants’ motivation and task adher-
ence, feedback is provided during the breaks, includ-
ing the average response time so far as well as the
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percentage correct responses. At the end of each training,
participants receive feedback on their performance during
the whole session, which they are asked to write down in
a booklet, such that they can keep track of their perform-
ance during the two weeks of training.
Assessment and training trials are preceded by a short
block of practice trials. During these trials, five neutral
NAPS and five neutral UMEA face pairs are presented,
with the arrow appearing with equal probability at each
location. Participants repeat the practice trials until they
accurately respond to eight of the ten trials. Feedback is
provided on each trial: either “correct” when they cor-
rectly indicate the direction of the arrow, or “incorrect”,
if they incorrectly indicate it’s direction. At post-test, the
assessment is followed by 100 re-training (or ST) trials,
during which 25 out of the 50 picture pairs are pre-
sented four times each (i.e., 15 NAPS pairs, 10 UMEA
pairs), to ensure that training effects are not diminished
by the post-assessment.
Primary outcome measures
The main outcome measures are change in attentional
bias, change in depressive symptomatology and mood
response and recovery from stress.
Attentional bias
Change in attentional bias is assessed by means of the
dot-probe task. In accordance with previous research
[33], an attentional bias score is calculated for each par-
ticipant, separately for pre- and post-assessment, by sub-
tracting RTs on trials where the arrow replaces the
positive picture (compatible trials) from trials where the
arrow replaces the negative picture (incompatible trials).
A positive score indicates an attentional bias towards
positive pictures, whereas a negative score indicates a
bias towards negative pictures.
Depressive symptoms
Changes in depressive symptoms are assessed with the
IDS-SR self-report [52]. The IDS-SR contains 30 items
that are rated on a 4-point scale (0 to 3). Possible total
scores can thus range from 0 to 90 with higher scores
indicating greater depression severity (i.e., 0–13 = no de-
pression; 14–25 =mild depression; 26-38 =moderate de-
pression; 39–48 = severe depression; > 48 = very severe
depression. The IDS-SR is well validated and has been
proven useful in detecting symptom change and residual
symptoms in depressed patients [55].
Mood reactivity and recovery from stress
To investigate training effects on mood changes in re-
sponse to a stressor, an adapted version of a speech task
as used by Sanchez et al. [22] is used. At the beginning
of this task, participants sit in front of a black computer
screen and rest for a period of five minutes. Afterwards,
they rate their mood, and are then informed by means
of computer instructions, that they will get two minutes
to prepare a five-minute-speech on the topic – e.g.,
“Why am I a good friend?”. This topic has effectively in-
duced stress levels in patients with MDD in the study of
Sanchez and colleagues. Participants are told that the
speech will be video recorded and evaluated on its quality
by two independent researchers. However, they are also in-
formed that not everybody would have to give the speech
eventually. Instead, the computer would randomly choose,
who actually has to give the speech. During the following
two-minutes of preparation, participants are allowed to take
notes with pen and paper and, to increase the stress level, a
clock on the computer-screen signals the time left. After
preparation, participants again rate their current mood be-
fore the computer informs them, that they would not have
to give the speech. They are then given another five mi-
nutes to rest and rate their mood for a last time afterwards.
This procedure has successfully been used by Sanchez and
colleagues to investigate the relation between attention bias
and stress responses in depressed individuals.
Mood changes during the speech task are measured by
means of a six-item, state version of the Spielberger
State-Trait Anxiety Inventory (STAI; [56, 57]) and a state
version of the international short form of the Positive
and Negative Affect Schedule (I-PANAS-SF; [58]). The
STAI-S contains six items related to anxiety (i.e., calm,
tense, upset, relaxed, content, worried) that are rated on
a 4-point scale (1 = not at all to 4 = very much). This
short form of the STAI has been proven sensitive to
fluctuations in state anxiety and shows comparable psy-
chometric properties as the full-form [56]. The I
PANAS-SF contains five items related to positive and
five items related to negative affect, rated on a five-point
scale (1 = very slightly or not at all to 5 = extremely) and
has shown to be psychometrically acceptable [58].
Secondary outcome measures
Trait anxiety
In line with earlier research on the effects of repeated
Cognitive Bias Modification (CBM) sessions in depression
[33], the 20-item Spielberger State-Trait Anxiety Inventory
(STAI-T; [59]), is used to assess anxiety proneness. All
items are rated on a Likert-scale ranging from 1 (not at
all) to 4 (very much). The Dutch translation of the scale
exhibits good psychometric properties [60, 61].
Positive and negative affect
To assess changes in general mood, the Positive and
Negative Affect Schedule (PANAS; [62, 63] is used. The
PANAS is a 20-item self-report measure consisting of
two mood scales, one assessing positive and one asses-
sing negative affect. Items are rated on a 5-point scale
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ranging from 1 (very slightly or not at all) to 5 (ex-
tremely). The Dutch translation of the PANAS has
adequate psychometric properties [64].
Rumination
Ruminative thinking is assessed with the Ruminative Re-
sponse Scale (RRS-NL), a subscale of the Response Styles
Questionnaire (RSQ; [65]). This self-report scale contains
22 items assessing an individuals’ tendency to engage in
rumination that is either self-focused (e.g., “think what am
I doing to deserve this?”), symptom focused (e.g., “think
about how hard it is to concentrate”) or focused on causes
and consequences of having a depressed mood (e.g., “think
I won’t be able to concentrate if I keep feeling this way”).
Items are rated on a 4-point scale, ranging from 0 (almost
never) to 4 (almost always). Next to a total rumination
score, this questionnaire provides brooding and reflective
pondering subscale scores, with brooding being consid-
ered the maladaptive component of rumination, which is
associated with more depression [66]. The psychometric
properties of the Dutch translation of the scale have been
proven to be moderate to good [67].
Resilience
Resilience is assessed with the Resilience Scale (RS;
[68]). This self-report questionnaire contains 25 items
(e.g., “I feel that I can handle many things at a time.“),
rated on the four-point scale (i.e., 1 = strongly disagree to
4 = strongly agree). The Dutch translation of the scale
has been shown to be a reliable and valid instrument to
measure the degree of individual resilience [69].
Cognitive transfer measures
To assess transfer to an attentional bias for verbal nega-
tive and positive information, the emotional Stroop task
[70] is used. This task consists of three randomized
blocks with valenced words (negative, neutral, and posi-
tive) that are presented in red, yellow, green, or blue on
a computer screen. The words are selected from a data-
base [71] and are matched for length and valence
strength. Participants are instructed to indicate the ink
color by naming the color of the word aloud, while ig-
noring the meaning of the words. The experimenter re-
cords reaction time (RT) and errors per block. A bias
score is calculated by subtracting the RTs for the positive
(negative) block from the reaction time for the neutral
block. A positive score is indicative for an attentional
bias for positive (negative) words.
The classical Stroop color naming task [72] is adminis-
tered in order to (1) explore whether trait differences in
cognitive control predict training effects on bias, and (2)
to assess transfer effects of the training on cognitive
control. As in the emotional Stroop task, participants
have to name the color of words or crosses while
ignoring their content. On neutral trials, rows of colored
crosses are presented (e.g., “xxxx” printed in green). On
congruent trials, color words are presented while the
meaning of the word and its print color match (e.g., the
word “green” printed in green). On incongruent trials, the
meaning of the color words and its print color do not
match (e.g., the word “green” printed in red). On these tri-
als, participants thus have to inhibit their automatic re-
sponse to read the word, resulting in slower RTs and more
errors when naming the colors compared to on neutral
trials. RTs to neutral (congruent) trials are subtracted from
RTs to incongruent trials. Higher positive scores accord-
ingly are indicative for less cognitive control.
In order to assess whether effects of the PT generalize
to other forms of cognitive biases in depression, in this
case the reduced ability to generate positive mental im-
agery of future events, the Prospective Imagery Task
(PIT; [73, 74]) is used. Participants have to form mental
images of ten positive and ten negative future scenarios
(e.g., “You will have lots of energy and enthusiasm” or
“You will feel misunderstood”) and to rate the vividness of
each image on a 5-point scale ranging from 1 (not imagine
at all) to 5 (very vivid). To obtain further information on
the quality of the generated images, participants rate how
much they feel as though they are actually experiencing
the event while imagining it (1 = not at all; 5 = completely),
how likely they think it is that the scenario happens to
them in the future (1 = not at all likely to occur; 5 = ex-
tremely likely to occur) and how much they feel as though
they are actually experiencing the event while imagining it
(1 = not at all; 5 = completely). Although, for this study,
we are primarily interested in positive mental imagery, we
also include the negative items to allow for control of the
general ability to generate prospective mental imagery. In-
ternal consistency has been calculated for a Dutch sample
by Blackwell and colleagues [75], where all subscales dem-
onstrated good internal consistency (α = 0.83–0.90). At
the end of the task, participants are asked to estimate how
often they had retrieved a memory from a past event in
order to vividly imagine the described scenario (i.e., 0–
100 % of the cases). To control for everyday use of mental
imagery when analyzing effects on positive imagery ability,
the Spontaneous Use of Imagery Scale (SUIS) [76] is ad-
ministered. The scale consists of 12 items, such as “If I am
looking for new furniture in a store, I always visualize
what the furniture would look like in particular places in
my home”, that are rated on a 5-point scale (1 = never ap-
propriate; 5 = always appropriate). The SUIS has good
psychometric properties and Blackwell et al. [75] report
good internal consistency in a Dutch sample (α = 0.81).
Process measures
Training task performance is assessed for both the PT
group and the ST group by comparing average RTs for
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incompatible trials (in the PT: catch trials) to average RTs
for compatible trials across training blocks and sessions.
Based on this, learning curves within each session and
losses of training effects between sessions will be investi-
gated. To evaluate effects of the online training sessions
on mood, three visual analogues scales (VAS) are adminis-
tered prior to and following each dot-probe session. The
VAS scales were adopted from Sanchez et al. [22] and
consist of three items each: happy mood (happy, optimis-
tic, joyful), anxious mood (nervous, tense, anxious), and
sad mood (depressed, upset, sad). Participants are asked
to indicate their current mood on a line with anchor
points ranging from 0 (not at all) to 10 (very much).
To control for possible placebo effects of the interven-
tion, the Credibility/Expectancy Questionnaire (CEQ; [77])
is used. The CEQ is a short self-report questionnaire that
measures how credible and convincing the patient experi-
ences the intervention and what the patient expects from
it. The questionnaire in this study has been adapted from a
Dutch version of this questionnaire for chronic back pain
patients [78]. It comprises three questions regarding the
credibility of the intervention and three questions assessing
participants expectations, all of which are answered on a 9-
point scale (1 = not at all to 9 = very much).
Cost-effectiveness
The Trimbos/iMTA questionnaire for Cost associated
with Psychiatric Illness (TiC-P; [79]) is used to measure
direct medical, direct non-medical and indirect non-
medical costs resulting from health care uptake and
productivity losses associated with MDD. The TiC-P is
the most widely used health service receipt interview for
economic evaluations in the Netherlands. The EuroQol
(EQ-5D-3 L) is administered to measure health related
quality of life [80]. It is a frequently used, preference-
based, generic index instrument for the calculation of
health-related quality of life in terms of quality adjusted
life years (QALYs; [81]).
Procedure
Eligible patients who agreed to participate, receive a
printed version of the TiC-P and are asked to fill it in at
home and bring it to the baseline session (session 1). At
start of this session, participants again receive written
and oral information about the study. Then, they provide
written informed consent and hand in the filled-in TiC-
P. In a computer room, first of all, a range of disorder-
related characteristics are assessed by the experimenter,
including the age of onset of the depression, the number
of depressive episodes during life time, the amount of
psychological treatment for previous episodes, as well as
information about the current episode (i.e., duration,
number of psychological treatment sessions, and duration
and dosage of pharmacological treatment). Afterwards,
participants are seated in front of a computer, where they
complete the dot-probe task (pre-assessment), which is
preceded by a brief assessment of mood state (VAS). Next,
they fill in computerized versions of all questionnaires
(i.e., IDS-SR, STAI-T, RRS, RS, PANAS, SUIS, EQ-5D-
3 L), before they complete the Stroop tasks. Finally, the
PIT is administered and an appointment is made for the
first training session, which again takes place at Pro Per-
sona, within 5 days after the baseline session. Although
the training is offered as web-based intervention, partici-
pants complete the very first training session under super-
vision of a researcher, to ensure that task instructions are
well-enough understood and that the task can be com-
pleted correctly at home. The importance of completing
the training by themselves, in a calm, distraction-free en-
vironment (i.e., without any music, television etc. on the
background) is emphasized, both verbally and in the writ-
ten task instructions. This is of particular relevance, as
previous research suggests that when working memory
load is high, which is likely the case in a home-
environment with task-irrelevant distractions, ABM may
be less or not effective [82].
During the first training session (session 2), partici-
pants receive written and verbal practical information
regarding the online training-program. They then
complete the first training which is, like all dot-probe
trainings, flanked by brief mood state measures (VAS).
Afterwards, the CEQ is administered and appointments
are made for the seven training sessions (session 3–9),
as well as for the post-assessment (session 10). The eight
training sessions are distributed across two weeks, with
four weekly sessions. During the two weeks of training,
participants receive automated e-mails reminding them
of the planned sessions. In case, participants do not
complete the planned sessions, even though they have
been reminded by e-mails, they are given a call by the
experimenter who asks them to still complete the ses-
sion. The post-assessment, which again takes place at
Pro Persona, is scheduled at least one week and a max-
imum of two weeks after the last training session. The
post-assessment is comparable to the baseline assess-
ment but without the Tic-P and the RS, and with the
additional speech task. Afterwards, appointments are
made for the subsequent follow-up assessments and par-
ticipants receive a reimbursement for their travel cost
(15 Euros).
During the first two follow-up assessments (session 11
& 12), participants complete questionnaires via the inter-
net (IDS-SR, STAI-T, RRS, RS, PANAS, EQ-5D-3 L). At
12 months follow-up (session 13), the MINI is adminis-
tered via telephone to assess the diagnostic status of de-
pression. Moreover, participants complete the IDS-SR,
EQ-5D and Tic-P via internet. After having filled in the
questionnaires, participants receive a debriefing form
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with contact information of the coordinating investiga-
tor, who can be contacted in case of questions. The use
of medication as well as the number of psychological
treatment sessions is monitored at the post-test and all
follow-up measures. For an overview of all measures and
corresponding time points, see Table 1.
Data-handling
The data is securely stored in a folder with limited
access by the involved researchers only and will be
retained for 15 years after inclusion. To assure confi-
dentiality, participant data (both paper-based and
electronic data) is identified by a participant ID (see
randomization and blinding). Electronic data is pro-
tected by a password. The file linking participant ID
and personal information is stored in a separated file
which is also password protected. To ensure data-
quality, paper-based data entry will be double
checked. Only the principal investigator and first au-
thor will have access to the final data-set. As the
study involves low to negligible risk, no additional
data monitoring committee is assigned. Results of this
study will be published in national and international
journals and will be presented at conferences. More-
over, participants and involved clinicians will receive a
summary of the study results.
Analyses
Sample size
Wells and Beevers [29] reported a large effect of ABM
on change in bias (η2 = .16) and on depressive symptoms
(η2 = .32). Likewise, Beevers et al. [35] observed a large
effect for change in bias from pre- to post-ABM within
the training condition (d = 1.01, η2 = .20), but not the
control condition (d = .04, η 2 = .0004). However, the
above-mentioned studies were conducted in a sample of
dysphoric students [29] and in a sample of treatment-
seeking current MDD patients, some of whom received
pharmacological treatment [35]. In the present study,
ABM is provided during the waiting period for psycho-
therapy or in combination with pharmacological treat-
ment and/or psychotherapy (i.e., IPT, CBT, psychiatric
care). In order to account for the greater heterogen-
eity of our sample and because recent meta-analyses
of the effects of CBM in anxiety and depression sug-
gest rather small effects [28, 41], we conservatively
assume a small to medium effect size of η2 = .02 (i.e.,
f = .142). A-priori sample size is calculated with
G*Power for F-tests for repeated-measures (RM) Ana-
lysis of Variance (ANOVA) with within-between inter-
action effects and an effect size specification as
recommended by Cohen [83]. To be able to detect
this effect size over two time-points, with an α-level
of .05 and a power-level of .80, a total sample size of
Table 1 Overview of all measures and corresponding time points
Domain Target Concept (Measure) T0 T1 Training 1 Training 2–8 T2 T3 T4 T5
Screening measures Inclusion Criteria Interview •
Diagnostic status (MINI) • •
Primary outcome measures Attentional Bias (Dot-probe) • •
Depressive Symptomatology (IDS-SR) • • • • •
Mood response and recovery from speech
task (I PANAS-SF & short STAI-S)
•
Secondary outcome measures Trait Anxiety (STAI-T) • • • •
Positive and Negative Affect (PANAS) • • • •
Rumination (RRS) • • • •
Resilience (RS) • • •
Cognitive transfer
-Verbal attentional bias (emotional Stroop task)
-Attentional control (classical Stroop task)
-Mental imagery (PIT, SUIS)
• •
Process measures Attentional Bias (Dot-probe training trials) • •
Mood in response to training (VAS) • •
Credibility and Expectancy (CEQ) •
Cost-effectiveness Quality of Life (EQ-5D-3 L) • • • • •
Costs (TIC-P) • •
Note. T0 = Intake; T1 = Baseline; T2 = Post-assessment; T3 = One month follow-up; T4 =Six months follow-up; T5 = 12 months follow-up; Measures at T1, Training 1
and T2 are administered by an experimenter, who is blinded to the training conditions. Training 2–8 and all follow-up measures (T3–T5) are administered via
the internet
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100 would be needed, thus 50 participants per group.
Compensating for an expected attrition of 20 %, we
need to include 50/0.80 = 62.5, thus 63 participants
per condition and N = 126 in total.
Analysis plan
Clinical evaluation
In accordance with the Consolidated Standards of
Reporting Trials (CONSORT; [84]), all analyses of the
primary and secondary outcome parameters will be car-
ried out in accordance with the intention-to-treat (ITT)
principle. Missing values due to drop-out will be imputed
(e.g., by using multiple imputation (MI) or expectation
maximization (EM)). Additional sensitivity analyses will
be conducted to gauge the robustness of the findings, by
including and excluding these participants in the analysis.
ABM effects on the primary outcome measures, atten-
tional bias and depressive symptoms, will be tested by
means of RM ANOVAs, with condition (PT, ST) as
between-subjects factor and time (pre-test, post-test) as
within-subjects factor. Likewise, training effects on stress
responses will be investigated with a 2 (condition: PT,
ST) × 3 (time: before stress, anticipatory stress, stress re-
covery) RM ANOVA with I PANAS-SF and STAI-S
scores as dependent variables. All analyses will be con-
ducted with and without covariates, in case variables are
unevenly distributed across groups (e.g., bias or depression
at baseline, number of previous depressive episodes, or
number of completed training sessions), to test the robust-
ness of the results. To investigate long-term effects of
ABM on depressive symptoms, the analysis of this primary
outcome parameter will be repeated over five time points
(baseline, post-test, one, six, and 12 months follow-up).
Effects on secondary outcome measures will be ana-
lyzed by means of ANOVAs or ANCOVAs over two
time points (baseline, post-test) in case of the cognitive
transfer measures, and over four time points (baseline,
post-test, one and six months follow-up), in case of ru-
mination, positive and negative affect, and resilience.
Exploratory analyses will be directed at the process
measures and will additionally be performed to take the
role of potential moderators into account, such as timing
of the training (i.e., during waiting period vs. next to
UC) type of UC (IPT, CBT, psychiatric care), or to pre-
dict training effects based on other disorder-related
characteristics assessed during baseline.
Finally, mediation analysis will be conducted to investi-
gate whether change in attentional bias across sessions
mediates the relationship between training condition and
depressive symptoms. A second exploratory mediation
analysis will test the mediating effect of rumination. This
analysis will only include participants who completed an
adequate dose of training sessions (i.e., 6–8).
As alternative to general linear models (GLM), which
have been the standard approach to analyzing data of
similar trials as the one proposed, more recent statistical
developments including linear mixed models (LMM)
might be considered when analyzing the data.
Economic evaluation
The Economic evaluation will be conducted in two ways.
First, we will conduct a cost-effectiveness analysis (CEA)
with treatment (i.e., UC + PT versus UC + ST) response
as the clinical outcome of interest. A probabilistic med-
ical decision-making approach is chosen, as costs are as-
sociated with large standard deviations and powering the
trial for testing an economic hypothesis would require
an extremely large sample size. Treatment response will
be based on a binary outcome, namely the clinical out-
come “depressive symptoms” (i.e., the IDS-SR score), and
will be computed as a 50 % (or better) pre/12 months
follow-up symptom IDS-SR reduction. Second, we will
conduct a cost-utility analysis (CUA) using quality ad-
justed life years (QALYs, based on the EQ-5D-3 L) as a
generic measure of health gains. Both the CEA and the
CUA will be conducted from the societal perspective and
in agreement with the ITT principle. The trial’s follow-up
measurements will not exceed one year and therefore
neither costs nor effects will be discounted. Sensitivity
analyses will be directed at uncertainty in the main
cost-drivers.
Four types of costs will be considered: (1) the costs of
offering the intervention, (2) costs stemming from health
care uptake including the costs of medication, (3) pa-
tients’ out-of-pocket costs, (4) costs stemming from
productivity losses due to absenteeism and lesser effi-
ciency while at work. The first two types of costs are also
known as the direct medical costs and these will be
based on the full economic costs of offering the training.
For this we shall make use of the pertinent Dutch guide-
line for economic evaluation [85] and use the standard
cost prices reported therein for the reference year 2014.
The patients’ out-of-pocket costs are also known as dir-
ect non-medical costs and encompass the patient’s costs
of travelling to health services, parking costs of the pa-
tient while travelling to and from treatment. Finally,
productivity losses will be based on the mean friction
costs, as outlined in the Dutch guideline for costing.
Data on resource use (health care uptake) and product-
ivity losses will be collected with the latest version of the
TiC-P [79]. Importantly, in both conditions, costs of
health care uptake (UC) will be evaluated. However, only
in the PT condition, the costs of the intervention will be
added, because that would best reflect the incremental
costs of adding the new intervention onto the current
package of UC and thus helps to answer the relevant
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question, if adding the new interventions offers good
value for money.
The incremental cost-effectiveness ratio (ICER) will be
computed to obtain the costs per treatment response
and the costs per QALY gained. Stochastic uncertainty
will be handled using 2500 non-parametric bootstraps
and plotting the simulated ICERs on the ICER plane.
For decision-making purposes, the ICER acceptability
curve will be plotted for various willingness-to-pay
(WTP) ceilings, which helps to making judgments
whether the intervention offers good value for money
relative to UC without PT. One-way sensitivity analyses
directed at uncertainty in the main cost drivers will be
performed to gauge the robustness of our findings across
a range of likely values of those parameters.
Discussion
Despite the range of available, evidence-based treatment
options for MDD, the rather low response and remission
rates [5–7] suggest that treatment for depression is not
optimal, yet. Considering the increasing demand for men-
tal health care, the associated costs and limited resources,
adding easily accessible computerized interventions as
adjunct to regular treatment services of depression, is an
appealing and likely efficient option when aiming at treat-
ment optimization.
ABM might have the potential to be provided as such
a cost-effective intervention during waiting period for
UC or next to the regular treatment sessions by bringing
more patients into remission and by reducing face-to-
face sessions, especially when being provided via inter-
net. Although the number of ABM studies in depressed
samples is still limited and findings are somewhat mixed
[34, 35], existing literature provides encouraging evi-
dence that ABM may indeed decrease depressive symp-
toms in sub-clinically depressed [29] and clinically
depressed individuals [29, 32, 35] and thus may have
therapeutic value. Most of these previous studies have
however limited their scope, by focusing on ABM effects
on depressive symptoms and rumination in non-clinical
samples, outside mental health care institutions. More-
over, only one RCT has been conducted so far, testing
the long term effects on symptoms (i.e., up to seven
month after training [32]).
To the best of our knowledge this is the first RCT exam-
ining the long-term effectiveness and cost-effectiveness of
an internet-based ABM intervention in clinically de-
pressed patients, in a specialized mental health care set-
ting. Based on the extensive literature showing that
depression is characterized by heightened attention for
negative information and a lack of attention for positive
information [86], we investigate whether a dot-probe
based ABM training away from negative and towards
positive pictures is therapeutically effective compared to a
placebo (i.e., sham ABM) training. Moreover, it is tested
whether ABM effects on symptoms are indeed mediated
by a change in attentional bias, as suggested by earlier re-
search [29].
Next to the long-term effects on clinical symptoms of
depression, the present study further aims at extending
findings of previous studies, by investigating whether the
training affects emotion regulation in response to stress
and general levels of resilience. Regarding the mecha-
nisms of symptom change, it is assumed that effects on
symptoms manifest themselves over a longer period of
time, after the bias has been repetitively deployed in
stressful daily life situations [17, 40]. Although there is
evidence that the prolonged processing of negative infor-
mation is related to impaired mood recovery after stress
[22], this is the first study examining the causal link be-
tween attentional bias and stress responses in depression.
Moreover a range of exploratory questions are ad-
dressed. To get more insight into mechanisms associated
with symptom change, we additionally test the mediating
role of rumination in ABM effects. Second, transference
effects to attentional bias for verbal materials and to
other cognitive measures, including cognitive control
and prospective positive mental imagery are investigated.
Third, the credibility of the training and related ex-
pectancies are measured and controlled for. The latter
will not only provide insight into the role of placebo
effects within ABM research, but may also give an in-
dication of the acceptance of such a computerized
training among patients.
Altogether, this study will enhance our understanding
regarding the role of attentional bias in depression and
the potential therapeutic effectiveness of ABM in this
population. To our knowledge, this is the first study test-
ing the cost-effectiveness of an ABM training in clinic-
ally depressed patients in a specialized mental health
care setting. It thereby also provides insight into the
combination of UC and ABM and whether adding such
an internet-based intervention, requiring limited to no
time of experienced clinicians, is indeed economically
sensible. If the training shows the expected beneficial
effects, this study will form an important step to-
wards the implementation of ABM in clinical practice
and the optimization of UC through computerized
self-help trainings.
Endnote
1The DSM-IV-TR is still used for diagnostic purposes at
mental health care institutions in the Netherlands until
2017. Therefore, the inclusion criteria in this study are still
based on this former DSM version, instead of on the
DSM-V. As the main criterion symptoms applied to the
diagnosis of a major depressive episode and the requisite
that these symptoms have to be present for at least two
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weeks do not differ between the two versions of the DSM
[87], relying on the DSM-IV-TR for inclusion is not con-
sidered problematic.
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